Sleep of good quantity and quality is considered a biologically important resource necessary to maintain homeostasis of pain-regulatory processes. To assess the role of chronic sleep disturbances in pain processing, we conducted laboratory pain testing in subjects with primary insomnia.
Introduction
Good sleep quantity and quality appear to have a physiologically important role in the regulation of pain processing (for a review, see Haack et al., 2009 ). Substantial clinical evidence provides support for a bi-directional relationship between sleep quantity/ quality and spontaneous pain (Affleck et al., 1996; Lee et al., 2009) . Experimental studies in healthy volunteers demonstrate that sleep restriction for one or more days, or total sleep deprivation, leads to the development of new onset spontaneous pain (Haack and Mullington, 2005; Haack et al., 2007) . Additional experimental human studies have shown that restriction of sleep at various stages for one or more nights, or total sleep deprivation, increases sensitivity to experimentally evoked pain (Cooperman et al., 1934; Moldofsky and Scarisbrick, 1976; Older et al., 1998; Onen et al., 2001; Kundermann et al., 2004; Roehrs et al., 2006; Smith et al., 2007) .
In order to better understand the role of sleep in pain processing, it is important to assess whether sleep affects the ability to centrally modulate pain. Deficiencies in the capacity to modulate pain appear to contribute to the susceptibility to acquire a pain disorder (Pud et al., 2009; Van Wijk and Veldhuijzen, 2010) . Central pain modulation originates from a network of descending pathways projecting from various cerebral areas to the dorsal horn, where the transfer of nociceptive input is then either facilitated or inhibited (Millan, 2002) . Methods that have previously been used to address questions about pain modulatory processes are the diffuse noxious inhibitory control (DNIC) paradigm (Le Bars et al., 1979) , in which the descending inhibitory responses are challenged during a conditioning pain-inducing stimulus, and the paradigm of temporal summation of pain, which is utilized to assess a potential mechanism of central pain facilitation (Herrero et al., 2000) . Abnormalities in pain modulatory processes have been reported in a variety of pain syndromes, including arthritis, chronic tension-type headache, migraine, temporomandibular disorder (TMD), irritable bowel syndrome, neuropathic pain, and fibromyalgia (Milanov and Bogdanova, 2003; van Wijk and Veldhuijzen, 2010) .
Though pain-modulatory mechanisms have rarely been studied in the context of insufficient sleep, there is some recent clinical evidence in TMD patients that altered pain-modulatory systems, as seen by a lower ability to inhibit pain, are associated with poor sleep, specifically, lower sleep efficiency and shorter total sleep time . Further, in an experimental setting, Smith and colleagues showed that healthy women have decreased pain-inhibitory capacity after three nights of experimentally fragmented sleep (Smith et al., 2007) . While these studies provide support for the relationship between sleep and pain at multiple levels (e.g., spontaneous pain, pain sensitivity, pain modulatory mechanisms), they are based on the study of either healthy participants or clinical pain populations, and therefore cannot address how alterations in sleep quality/quantity may lead to changes in pain processing independent from co-morbid illness and other factors. The current study tested the role of chronic sleep disturbances on alterations in pain processing by conducting experimental pain testing in otherwise healthy subjects with primary insomnia and a healthy comparison sample.
Methods

Participants
Seventeen participants with primary insomnia and 17 individually age-and sex-matched healthy controls with good quantity/ quality sleep completed the study (see Table 1 ). Participants were recruited through advertisements on public transportation and radio, as well as through online advertisements and paper fliers posted at Boston area colleges. Participants with insomnia met full diagnostic criteria for primary insomnia disorder based on the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV-TR, American Psychiatric Association, 2000). Specifically insomnia participants were required to have difficulties initiating sleep, maintaining sleep, or waking up too early for at least one month in duration that was not caused by a medical or psychiatric conditions, or (Schramm et al., 1993) . No participants could be undergoing any medical treatment or taking any medication (including hypnotic/sleep medications) at the time of study. Additional questionnaires were used to assess sleepwake habits and medical history (SF-36, (Ware et al., 2000) , Pittsburgh Sleep Quality Index (PSQI, Buysse et al., 1989) , Patient Health Questionnaire (PHQ-I, Kroenke et al., 2001) , and the research version of the Structured Clinical Interview for DSM-IV-TR Axis I disorders (SCID, First et al., 2004) ). Exclusion criteria were the presence of any Axis I disorder (e.g., major depressive disorder, generalized anxiety disorder, alcohol abuse) in the last six months, or any medical disorders, ongoing painful conditions, or sleep disorders other than primary insomnia. All participants were also required to provide a statement from their primary care physician indicating that the participants were healthy except for primary insomnia.
Study protocol
The institutional review board at the Beth Israel Deaconess Medical Center approved the study and participants provided written informed consent for study participation. Following an initial screening visit (Visit 1), eligible participants were provided with an actigraph and a sleep diary to record their habitual sleepwake habits across a 2-week period. For their second visit (Visit 2), participants were asked to come fasted to the research center. They were oriented to the study protocol and allowed to rest quietly in a temperaturecontrolled room for one hour prior to the start of any study procedures. At 13:00, 1 h after lunch was served to participants, they were seated in a comfortable chair for the experimental pain testing session. The first two procedures (warmth and heat pain detection thresholds, pressure pain thresholds) were followed by a brief break during which the participants were interviewed by a study nurse and were given the option to opt out of the study if the participants deemed the pain-inducing tests too distressing. After the break, temporal summation and Diffuse Noxious Inhibitory Control (DNIC) were tested. The entire testing battery lasted a maximum of 1.5 h. The room temperature was set to 25°C at the Research Center testing rooms; nurses adjusted room temperature hourly to maintain temperature continuity and participant comfort. The majority of the pain testing sessions (i.e., 32 out of the 34 sessions) were administered by the same experimenter (JSS), who was blind to the condition of the participant (i.e., insomnia vs. control).
Spontaneous pain ratings
At bedtime for two weeks prior to the in-laboratory testing, participants documented the intensity of daily spontaneous pain symptoms using a VAS (0 -not experienced at all to 100 -experienced with very high intensity) included on their sleep diaries. The sites of pain included head, joints, muscles, back, and abdomen, as well as two ratings assessing physical discomfort and general body pain. For each pain symptom, pain frequency was calculated by dichotomously coding of daily VAS scores of less than 5 as 'no pain' and ratings greater or equal to 5 as 'pain'. A cut-off value of 5 was chosen to increase discriminative power. Pain frequency was then expressed as the number of days with pain out of the 14-day assessment period for each pain symptom. Pain intensity was calculated by averaging pain intensity ratings across days when pain was present for each item. In addition, individual pain symptoms were averaged for each study day, in order to calculate global spontaneous pain frequency and intensity scores, respectively. (1) Warmth detection thresholds (WTh) were assessed using the TSA-II NeuroSensory Analyzer (Medoc, Minneapolis, MS). A Peltier thermode, size 30 ¥ 30 mm 2 was secured on the inner palm of the non-dominant hand. From a baseline temperature of 32°C, the thermode was heated at a rate of 0.5°C/s. Participants were requested to press a control button at the first instant of the sensation of warmth. The stimuli were presented in a train of four with an interstimulus interval of 10 s. The mean of the response times was calculated to be the detection threshold.
Experimental pain testing protocol
(2) Pain sensitivity: Heat pain thresholds (HPTh) were obtained using the same method described above for WTh, although in this protocol participants were asked to press a control button at the first instant of the sensation of pain (rather than warmth). The stimuli were presented in a train of four at a rate of 0.5°C/s and inter-stimulus interval of 10 s.
Pressure pain thresholds (PPTh) were obtained with use of an electronic pressure algometer (Somedic Sales AB, Hörby, Sweden). Thresholds were assessed at the middle phalanx of the middle and ring finger, following a training session conducted on the index finger. A 1.0 cm 2 circular probe was positioned on the finger (Brennum et al., 1989) and the pressure was increased at a rate of 30 kPa/s (cut-off limit was 850 kPa). Participants were instructed to press a control button when they experienced the first sensation of pain. A train of four pressure-pain stimuli were applied at a 15 s intervals and the average of these stimuli was calculated as the pressure pain detection threshold.
(
3) Tests involving pain-modulatory mechanisms:
Temporal Summation (TS) was assessed with the TSA-II Neuro-Sensory Analyzer (Medoc, Minneapolis, MS). Using the thermode, four sequences each consisting of ten brief consecutive heat pulses were applied to the non-dominant forearm volar skin. The temperature of the thermode increased and decreased at a constant speed and the pulse-to-pulse interval was 2.5 s. The temperature used to assess TS was tailored to each person's tolerance level as previously described (Edwards and Fillingim, 2001; Edwards et al., 2003) . This procedure was chosen due to large inter-individual differences in pain detection at a given temperature. The first test sequence of this individually-tailored procedure had a target temperature of 48°C and an inter-pulse temperature of 42°C. Depending on whether the participant tolerated the initial 10-pulse sequence, the target and inter-pulse temperature of the second sequence was increased or decreased, respectively, by 1.5°C (i.e., increased to 49.5°C with an inter-pulse temperature of 43.5°C or decreased to 46.5°C with an inter-pulse temperature of 40.5°C). In the third sequence, the target and interpulse temperatures were again increased or decreased by 1.5°C, depending on whether the participant could tolerate the second sequence or not. The intersequence interval was 2 min at a temperature of 32°C. The thermode was moved systematically between sequences, starting at the thenar eminance for a practice trial, and sequentially moving cephalad on the volar aspect of the forearm along the innervation of C5-6 for the remaining three trials. This sequence was designed to prevent testing on previously stimulated skin areas (see Figure 1) .
During each test sequence, participants were prompted to rate the intensity of the 1st, 4th, 7th, and 10th thermal pulse using a 0-100 mm visual analogue scale (VAS). A research assistant assisted with the administration of VAS intensity rating scales, which were presented on separate data sheets for each rating. The participant was instructed to say 'STOP' as soon as the sensation was no longer tolerable at any point during the testing. Temporal summation of pain is defined as an increase in perceived pain intensity across the 10-pulse sequence, such that the last heat pulse intensity in a sequence is perceived as more painful than the first. For statistical analysis between groups (insomnia vs. control), the time course of pain intensity ratings across the TS sequence was compared between groups. For correlational analysis, a single value for TS was calculated by only taking into account the change between the ratings of the first and last stimulus (10th minus 1st stimulus). Higher 
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Figure 1 Position of the thermode during pain testing Position X was used for training trials. Position 1 was used for heat pain threshold testing. Positions 2, 3, and 4 along the innervation of C5-6 were used for the three sequences of TS testing. Positions 5-8 along the innervation of C8-T1 were used for the four trials of DNIC testing. The thermode was moved in a systematic fashion in order to prevent sensitization or habituation effects due to repeat testing at the same site.
values of this change score indicated greater temporal summation of pain.
Diffuse Noxious Inhibitory Control (DNIC). For this protocol, the test stimulus was the TS sequence at highest tolerable temperature, applied to the outer volar surface of the non-dominant forearm, along C8-T1 innervations (see Figure 1) . Immersion of the contralateral foot into a hot water bath (47°C) was the conditioning pain stimulus that is intended to activate the pain-inhibitory circuits and thereby decrease the perceived pain of the forearm test stimulus. In total, four DNIC trials were performed: two trials using a hot water bath (47°C) and two trials using a neutral water bath (22°C). The neutral water bath trials served as a distractioncontrol condition. The trial sequence was applied randomly in the order of hot-neutral-hotneutral or neutral-hot-neutral-hot, with the order counter-balanced within groups. Techne® water baths were used (Bibby Scientific US, Burlington, NJ); the hot water bath temperatures were maintained with a clip-on Tempette thermoregulator (TE-10D, Bibby Scientific US, Burlington, NJ), which heated the water temperature to 47°C, circulated, and controlled water temperature within precise limits. Shortly before each foot immersion, the thermoregulator was removed from the water to comply with hospital safety regulations. Each water bath had a traceable thermometer (Control Company, Friendswood, TX) to assess water temperature throughout foot immersion.
For each trial, the participant's foot was first submerged in the water bath. After 20 s of immersion, the 10-pulse temporal summation sequence was applied to the forearm and the participant was prompted to rate the pain intensity of the 1st, 4th, 7th, and 10th stimulus using the VAS. After the last stimulus in each series, the participant was prompted to rate the intensity and unpleasantness of the sensation on the foot, before the foot was removed from the water. There was a two-minute rest period between all trials during which the thermode was systematically moved from the distal to proximal sites along the C8-T1 innervated skin (see Figure 1 ) in order to avoid re-stimulation of the previously sensitized skin.
For statistical analysis, ratings of the two 10-pulse sequences under the conditioning stimulus or distraction-control stimulus, respectively, were first averaged, so that each of the 1, 4, 7, and 10th pulse was presented by the average of 2 ratings. For comparison between groups of insomnia and controls, all four ratings of the 10-pulse sequence under either the conditioning stimulus or distraction-control stimulus were included in the model and contrasted against the four ratings of the 10-pulse sequence alone (i.e., baseline, without foot immersion). In case of an interaction effect between ratings over time and group, this effect was explored by contrasting sequences against each other within groups as well as between groups. For correlational analysis, a single value for DNIC was calculated by only taking into account ratings of the first and last stimulus (10th minus 1st stimulus). The change score from the 10-pulse sequence alone was then subtracted from the 10-pulse sequence under conditioning pain or distraction-control stimulus, and a lower value was indicative of greater pain inhibition.
Statistics
Univariate analyses were used to compare differences between groups for the following output variables: spontaneous pain frequency/intensity, warmth detection threshold [WTh] , heat pain threshold [HPTh] , and pressure pain threshold [PPTh] ). General linear model analysis for repeated measures was used to compare the time course of repeated measured variables (pain intensity ratings in temporal summation sequence) between groups. In the event of an interaction effect (p < 0.10), simple contrasts were run to detect which time points differed between groups. Pearson's coefficient was used for correlational analysis. PPTh were log transformed before statistical analysis because the data were not normally distributed. Data are presented as mean Ϯ SEM. An alpha value of p < 0.05 was considered as significant. An alpha value of p < 0.10 was considered as trend towards significance. Data were processed with PASW® Statistics 18 (www.spss.com).
Results
Sample characteristics of primary insomnia and the individually age-and sex-matched healthy control group are shown in Table 1 .
Spontaneous pain
Insomnia subjects reported pain symptoms on twice as many days as healthy controls during the 14-day recording period (9.4 Ϯ 1.0 days in insomnia subjects vs. 4.8 Ϯ 1.1 days in healthy controls; F[1, 32] = 9.24, p = 0.005; see Figure 2a ). This effect was mainly due to higher levels of physical discomfort (F[1, 32] = 6.88, p = 0.013) and generalized body pain (F[1, 32] = 5.15, p = 0.030), rather than pain experienced at specific sites, e.g., head, abdomen. Insomnia subjects also rated their pain as more intense than did healthy controls (20 Ϯ 16 vs. 12 Ϯ 7 units in insomnia vs. controls, respectively; F[1270 = 3.12, p = 0.09; see Figure 2b ).
Warmth detection threshold (WTh)
Six matched pairs were excluded due to a technical error. Detection threshold for warmth did not differ between groups (33.5 Ϯ 0.2°C vs. 33.6 Ϯ 0.3°C for participants with insomnia vs. controls, respectively; F[1, 20] = 0.02, p = 0.90), indicating normal perception of non-noxious warmth sensation in insomnia subjects.
Pain sensitivity
Heat pain thresholds (HPTh) were on average 3.5°C lower in subjects suffering from insomnia compared to matched healthy controls (p < 0.05, see Figure 3a) .
Pressure pain thresholds (PPTh) trended to be significantly lower in patients suffering from insomnia than healthy controls (p = 0.08, see Figure 3b ).
Tests assessing pain-modulatory mechanisms
Temporal summation (TS)
The highest tolerable temperature used with the repeated heat pulse sequence was lower in insomnia subjects, but did not significantly differ between insomnia subjects and healthy controls (48.9 Ϯ 0.30°C vs. 49.5 Ϯ 0.34°C; F[1, 32] = 1.91, p = 0.18). Because the temperature differences between group may influence outcome measures, it was used as a covariate in the statistical model with pulses of the sequence (1, 4, 7, 10) as the repeated measure factor, and group (insomnia vs. control) as the between subject factor. In this model, the intensity ratings of the heat pulse sequence showed a significant interaction effect with group (F[3, 93] = 3.71, <0.04, see Figure 4 ). While pain intensity ratings initially increased in both groups, ratings of the control group continued to increase while ratings in the insomnia group rapidly declined and dropped below baseline value at the last measurement point. These findings indicate that insomnia patients show a decreased, rather that the predicted increased, TS of pain.
We also compared the pain intensity ratings between insomnia and controls at a standard stimulus temperature of 48°C. As one insomnia subject did not tolerate this temperature, the sample size for this comparison decreased to N = 16 in the insomnia group and N = 16 in the age-and sex-matched control group. An interaction effect indicated a finding similar to the tailored TS temperatures (F[3, 90] = 2.29, p = 0.09 for interaction effect). Insomnia subjects showed a stronger decrease of pain intensity ratings of the last compared to the first stimulus (F[1, 15] = 6.96, p < 0.05), while a decrease over the stimulus sequence was not evident in the control group (F[1, 15] = 0.06, p = 0.80).
Diffuse noxious inhibitory control (DNIC)
Conditioning stimuli (hot and neutral water bath)
The pain intensity ratings of the hot vs. neutral water bath were 75 Ϯ 4 vs. 31 Ϯ 6 units in insomnia subjects, which was similar to controls (71 Ϯ 4 vs. 20 Ϯ 4 units, F[1, 32] = 0.78, p > 0.05 for interaction effect). As expected, there was a significant effect of hot vs. neutral water temperatures (F[1, 32] = 180.35, p < 0.001 in the total sample). Similarly, the unpleasantness ratings of the hot vs. neutral water bath were similar in insomnia and controls (65 Ϯ 6 vs. 20 Ϯ 6 units in insomnia participants and 61 Ϯ 6 vs. 7 Ϯ 3 units in control participants, F[1, 32] = 0.52. p > 0.05 for interaction effect), with a significant effect of hot vs. neutral water temperatures (F[1, 32] = 117.12, p < 0.001 in the total sample). Change of water temperature between the time of foot entry and exit from the water bath did not significantly differ between groups in either water temperature condition (neutral water bath, p = 0.07; hot water bath, p = 0.68). Thus, intensity and unpleasantness ratings, as well as change of water bath temperatures, did not differ between insomnia and controls and therefore do not confound ratings of the test stimuli.
Test stimuli (TS sequence)
Six out of 17 insomnia subjects (35%) and three out of 17 control subjects (18%) had their initial temperature reduced by 1.5°C after reporting intolerable/ unsustainable pain levels during the first trial. Because differences in temperature between groups may have affected outcome measures, it was entered as a covariate in the statistical model with pulses (1st, 4th, 7th, and 10th) and the TS sequence (baseline vs. conditioning pain condition) as repeated factors, and group (insomnia vs. control) as the between subject factor. A significant interaction effect of pulse ¥ sequence ¥ group indicated a difference in the timecourse of the TS sequences at baseline and conditioning stimulus between groups (F[3, 93] = 4.48, p < 0.02). In addition, comparing baseline with the distraction-control condition, a significant interaction between pulse x sequence x group was evident (F[3, 93] = 4.10, p < 0.03).
In healthy controls, there was less summation of pain intensity over the 10-pulse heat pulse sequence during both the exposure to conditional heat pain of the hot water bath and the conditional distraction stimulus of the neutral water bath, compared to baseline (i.e., TS sequence without additional exposure to conditional heat pain/distraction; Figure 5, left panel) . This result appears to reflect physiological activation of Pain sensitivity and modulation in primary insomnia M. Haack et al. endogenous pain-inhibitory circuits that are mediated by heat pain, distraction or both stimuli. In contrast, in insomnia subjects, the time course of pain ratings across the 10-heat pulse sequence during either exposure to the conditional heat pain or distraction neutral temperature stimulus was similar to the time course of pain ratings under baseline. This result implies a failure to mount an endogenous pain inhibitory response ( Figure 5 , right panel). It is of note that the pain intensity ratings and heat pulse response curve during the baseline TS sequence in insomnia participants ( Figure 5 ) resembles the curves observed in healthy controls during either conditional heat pain or distraction challenges. This suggests that maximum recruitment of pain-inhibitory circuits was already present at baseline in our insomnia participants, as no further response occurred during conditional heat pain or distraction challenge during DNIC testing. We also performed these analysis excluding the participants who re-adjusted temperature, as well as their matched pair (N = 10 in each group), and found similar effects as when statistically controlling for temperature re-adjustment in the entire sample (F[3, 54] = 9.38, p < 0.01 for interaction effect between pulse, sequence (baseline vs. conditioning pain stimulus), and group; F[3, 54] = 1.93, p = 0.14 for interaction effect between pulse, sequence (baseline vs. distraction-control stimulus), and group).
Correlations
Correlations were conducted between subjective wellbeing (SF-36, PSS-14), insomnia severity (PSQI, insomnia duration), subjective pain reporting across 2-week recording period, and experimental pain. In the total sample, the lower functioning on SF-36 subscales for general health, vitality, bodily pain, social functioning, role emotional, and mental health were correlated with higher levels of subjective pain frequency and intensity (all R > 0.35, p < 0.05). Additionally, the PSQI score correlated negatively with HPTh and maximal tolerable temperature in TS sequence (both R = -0.46, p < 0.01). With respect to subjective pain reports and experimental pain, a higher pain frequency correlated with a lower tolerable temperature in the TS sequence (R = 0.37, p < 0.05), but no other correlation in this domain reached statistical significance. Within experimentally assessed pain variables, HPTh and PPTh were positively correlated (R = 0.38, p < 0.05); but no other correlation in this domain reached statistical significance. Correlational analysis within groups of insomnia and controls showed that associations between above mentioned variables tended to be stronger in the insomnia group compared to the control group, and most of them only trended to reach significance due to small sample sizes (N = 17 in each group). 
Discussion
The current data provide the first empirical evidence that individuals with primary insomnia show abnormalities in pain processing. Specifically, this study demonstrates that individuals with primary insomnia experienced spontaneous pain more frequently and intensely, exhibit a higher sensitivity to evoked heat and pressure pain, and have a dysfunctional pain inhibition system compared to healthy individuals. These findings support the overall hypothesis that insufficient sleep, here observed in the form of insomnia, may contribute to the development or amplification of pain independent from the influence of medication or other medical disorders. This finding is of critical importance considering that insomnia is a very common form of sleep disturbance, with a lifetime prevalence of 25-33% (for review, see (Pigeon, 2010) ).
Spontaneous pain reporting
Cross-sectional and longitudinal studies have consistently reported that insufficient sleep and the subjective reporting of pain are interrelated. This association has been shown in the general population and in various clinical pain populations, as well as in experimental studies where one or more days of total or partial sleep deprivation led to an increase in the experience of spontaneous pain (see Section 1). Experimental studies have typically tested the effects of a more drastic, consistent decrease in sleep quality of quantity over a short period of time. In contrast, however, patients suffering from insomnia typically experience large day-to-day variability in both sleep duration and quality (Buysse et al., 2010) . Thus, the current study finding supports the hypothesis that the specific type of insufficient sleep in primary insomnia is likely to contribute to, or amplify, the experience of spontaneous pain.
Pain sensitivity
To our knowledge, pain sensitivity has not previously been assessed in patients suffering from primary insomnia independent from the influence of other psychiatric or pain-related disorders. We report here that these patients have significantly lower heat pain thresholds (by almost 3°C) and demonstrated a trend towards lower pressure pain thresholds. These changes were not due to a general change in somatosensory processing, as warmth detection thresholds were similar in insomnia and control participants.
Similarly, TMD patients with an additional diagnosis of primary insomnia have been reported to have increased pain sensitivity to pressure and heat pain stimuli compared to those without a sleep disorder . There is also strong evidence from experimental studies that insufficient sleep itself is able to increase pain sensitivity (see Section 1). The current study findings support that, beyond the experimental manipulation of sleep duration and continuity, the type of sleep disturbances experienced in primary insomnia contributes to an increase in pain sensitivity. At this point, it is not clear which aspects of sleep in primary insomnia are predictive of changes in pain sensitivity, such as duration, fragmentation, or even effects on daytime functioning (e.g., subjective sleepiness, which has been recently found related to pain sensitivity (Chhangani et al., 2009) ).
Pain-modulatory mechanisms
Findings from testing pain facilitation and pain inhibition, as assessed by temporal summation and DNIC, respectively, provide preliminary data that contributes to our understanding of the physiological mechanisms underlying central pain processing abnormalities in primary insomnia. While the temporal summation of heat pain response increased in healthy controls as has been observed previously, the responses in primary insomnia subjects unexpectedly declined to a level below baseline after an initial brief rise (Figure 4) . Temporal summation reflects a facilitation of the spinal neuronal response to repeated C fiber stimulation (Mendel, 1966) , and is often used as an index of the sensitizability of central pain transmission neurons (Herrero et al., 2000) . Stimuli used in the temporal summation sequence can also be strong enough to activate pain inhibitory circuits, thereby counteracting pain facilitation and leading to less active temporal summation (Gozariu et al., 1997) . These complementary actions of opposing pain-facilitatory and pain-inhibitory effects have also been observed during the development of inflammation. In experimental models of arthritis, for example, pain facilitation (e.g., spinal cord hyperexcitability evoked by inflammation) is counteracted by an increase in the effectiveness of descending inhibition (Schaible and Grubb, 1993) . With this in mind, our findings of less temporal summation in insomnia suggest that pain-inhibitory circuits are in constant activation, thereby counteracting the pain-facilitatory response (i.e., TS of pain) in this sample to a greater extent than is observed in healthy participants. Constant activation of the descending pain inhibition in insomnia may be the compensatory response to continually enhanced or amplified noxious input, as indicated by our findings of increased spontaneous pain and pain sensitivity in insomnia. Without this continuous counter-regulatory (pain inhibitory) effort, insomnia patients may have experienced even more spontaneous pain and have higher sensitivity to pain than was observed in this study. Alternatively, one may suggest that the lower tailored temperature used in the TS sequence for insomnia compared to control may have let to a quicker habituation in insomnia and contributed to current findings. However, as statistically controlling for temperature differences did not change the results this appears to be an unlikely explanation of the current findings.
Findings from the temporal summation test may suggest that the pain inhibition system in patients with primary insomnia is in a constantly activated state; this system failed to respond when directly challenged using the DNIC paradigm, further suggesting a prior state of maximal activation. While healthy control participants in the current study showed the expected pain-inhibitory effect under conditions of conditional heat pain (hot water), as well as distraction (neutral water), participants with primary insomnia were unable to inhibit pain under either of these conditions. Distraction is an effective stimulus to diminish pain and is frequently used as a pain coping strategy (Keogh et al., 2000) . While it has often been questioned whether pain inhibition in response to an additional painful stimuli is simply due to a distraction process, recent evidence supports that the mechanisms through which additional pain or distraction inhibit pain are largely separable (Moont et al., 2010; Lautenbacher et al., 2007) . However, it has to be kept in mind that the stimulus of a 22°C water bath in the current study may not represent a 'pure' distraction, as pain ratings of the neutral water bath averaged at about 30 and 20 units in insomnia and controls, respectively.
Several limitations may have influenced our findings and need to be addressed in the future. Though we systematically moved the thermode between TS sequences in order to prevent sensitization and utilized an inter-sequence resting interval of 2 min, we cannot be certain that sensitization did not take place. As such, a potential differential build-up of sensitization between groups may have affected TS and DNIC findings. Further, the inter-pulse baseline temperature used in each TS sequence was 6°C lower than the peak temperature (for example 42-48°C, 43.5-49.5°C), and high inter-pulse temperatures may have led to a more continuous pain sensation rather than distinct pulses. Furthermore, as DNIC testing under conditions of additional pain or distraction always followed baseline testing (without additional stimuli), repeated testing, rather than activation of pain inhibitory circuits, may have led to current DNIC findings. Controlling for sequence effects between baseline and DNIC testing will be necessary to follow-up on this potential confound in the future.
Our findings of a diminished response of descending pain inhibition to DNIC testing in the context of attenuated temporal summation of pain, elevated rates of spontaneous pain, and increased pain sensitivity in primary insomnia participants lead us to propose that pain-inhibitory circuits are in a state of constant activation in order to compensate for ongoing sub-clinical pain (as indicated by increased spontaneous pain), ultimately leading to a ceiling effect, i.e., a state of maximal activation of the pain inhibition system. As a result, both pain facilitation and inhibition functions, as quantified here by temporal summation and DNIC testing, respectively, are abnormal in participants with primary insomnia. This potential explanation of current study findings is speculative and will require longitudinal testing of pain symptoms and regulatory functions in a sample of participants with new onset insomnia.
This proposed maximal activation of the pain inhibitory system may have several consequences. For example, various analgesic medications that are known to reduce pain, in part through activation of pain-inhibitory circuits, may not be as effective in primary insomnia populations. These medications include commonly used non-steroidal antiinflammatory drugs (NSAIDS, (Rady et al., 2001) , as well as opioids (Millan, 2002) . Further, we suggest that the constantly activated pain-inhibitory circuits we propose in our young participants may eventually exhaust over the course of chronic insomnia. This transition may result in a dis-inhibition of pain processing and contribute to the transition from acute pain symptoms to chronic pain conditions, which are common comorbid disorders in insomnia populations.
